Gessler M - Search Results

1

The genomic landscape of pediatric renal cell carcinomas.

Beck P, Selle B, Madenach L, Jones DTW, Vokuhl C, Gopisetty A, Nabbi A, Brecht IB, Ebinger M, Wegert J, Graf N, Gessler M, Pfister SM, Jäger N. Beck P, et al. Among authors: gessler m. iScience. 2022 Mar 26;25(4):104167. doi: 10.1016/j.isci.2022.104167. eCollection 2022 Apr 15. iScience. 2022. PMID: 35445187 Free PMC article.

2

Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development.

Zirn B, Wittmann S, Graf N, Gessler M. Zirn B, et al. Among authors: gessler m. Cancer Lett. 2005 Mar 18;220(1):115-20. doi: 10.1016/j.canlet.2004.08.001. Cancer Lett. 2005. PMID: 15737694

3

All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.

Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, Gessler M. Zirn B, et al. Among authors: gessler m. Oncogene. 2005 Aug 4;24(33):5246-51. doi: 10.1038/sj.onc.1208725. Oncogene. 2005. PMID: 15897880

4

Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.

Wittmann S, Zirn B, Alkassar M, Ambros P, Graf N, Gessler M. Wittmann S, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2007 Feb;46(2):163-70. doi: 10.1002/gcc.20397. Genes Chromosomes Cancer. 2007. PMID: 17099873

5

New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors.

Wittmann S, Wunder C, Zirn B, Furtwängler R, Wegert J, Graf N, Gessler M. Wittmann S, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2008 May;47(5):386-95. doi: 10.1002/gcc.20544. Genes Chromosomes Cancer. 2008. PMID: 18260125

6

WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.

Wegert J, Wittmann S, Leuschner I, Geissinger E, Graf N, Gessler M. Wegert J, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2009 Dec;48(12):1102-11. doi: 10.1002/gcc.20712. Genes Chromosomes Cancer. 2009. PMID: 19760609

7

Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

Williams RD, Al-Saadi R, Chagtai T, Popov S, Messahel B, Sebire N, Gessler M, Wegert J, Graf N, Leuschner I, Hubank M, Jones C, Vujanic G, Pritchard-Jones K; Children's Cancer and Leukaemia Group; SIOP Wilms' Tumour Biology Group. Williams RD, et al. Among authors: gessler m. Clin Cancer Res. 2010 Apr 1;16(7):2036-45. doi: 10.1158/1078-0432.CCR-09-2890. Epub 2010 Mar 23. Clin Cancer Res. 2010. PMID: 20332316 Free PMC article.

8

Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.

Schmitt J, Heisel S, Keller A, Leidinger P, Ludwig N, Habel N, Furtwängler R, Nourkami-Tutdibi N, Wegert J, Grundy P, Gessler M, Graf N, Lenhof HP, Meese E. Schmitt J, et al. Among authors: gessler m. Int J Cancer. 2012 Aug 1;131(3):673-82. doi: 10.1002/ijc.26419. Epub 2011 Oct 23. Int J Cancer. 2012. PMID: 21913182 Free article.

9

Characterization of primary Wilms tumor cultures as an in vitro model.

Wegert J, Bausenwein S, Roth S, Graf N, Geissinger E, Gessler M. Wegert J, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2012 Jan;51(1):92-104. doi: 10.1002/gcc.20936. Epub 2011 Oct 27. Genes Chromosomes Cancer. 2012. PMID: 22034155

10

Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro.

Wegert J, Bausenwein S, Kneitz S, Roth S, Graf N, Geissinger E, Gessler M. Wegert J, et al. Among authors: gessler m. Mol Cancer. 2011 Nov 8;10:136. doi: 10.1186/1476-4598-10-136. Mol Cancer. 2011. PMID: 22067876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page